Navigation Links
Sosei Announces Approval to Start AD 923 Phase III Studies in Europe
Date:11/28/2007

TOKYO, November 28 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, today announces that it has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the Phase III clinical trial programme for its fentanyl sublingual spray (AD 923), an opioid analgesic for the treatment of cancer breakthrough pain.

The clinical trial authorisation (CTA) covers two multi-centre pivotal Phase III efficacy studies followed by an open label safety study. Patient enrolment in the UK is expected to commence before the end of the year and will be the subject of a separate announcement. Applications have been made in other European countries and further patient recruitment will be initiated as soon as approval is received from the relevant local regulatory body.

This first CTA in a major European country will also trigger the receipt of a project milestone payment under the AD 923 Licence Agreement signed with Mundipharma in June 2006.

Mr Shinichi Tamura, President & CEO of Sosei, said: "Receipt of our first Phase III CTA represents an important milestone in the evolution of Sosei and the continuing progress of the AD 923 development programme. We look forward to enlisting our first patients in the trial".

Notes to Editors:

About Sosei

Sosei Group Corporation is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit http://www.sosei.com

About AD 923

AD 923 is an optimised, sublingual formulati
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD
2. Sosei Announces Update on Phase I Trials for SD118
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 17, 2013 The distribution of white ... brain injury (MTBI) closely resembles that found in early ... in the journal Radiology. , “Findings of MTBI ... Alzheimer’s dementia,” said the study’s lead author, Saeed Fakhran, ... Neuroradiology at the University of Pittsburgh School of Medicine. ...
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... The distribution of white matter brain abnormalities in ... resembles that found in early Alzheimer,s dementia, according to ... Radiology . , "Findings of MTBI bear a ... said the study,s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. "Additional research ...
(Date:6/17/2013)... 17, 2013 Daimer Industries, Inc.®, a ... equipment , such as expertly designed carpet steam cleaner ... Pro Plus 200S for apartment dwellers and homeowners. The ... in 15 minutes and pressure levels up to 75 ... can be used to clean carpet spots and areas ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4
... (WASHINGTON, July 1, 2010) Older patients with Hodgkin ... high risk of hospitalization for cardiac complications after completing treatment, ... the journal of the American Society of Hematology. HL is ... and approximately 8,500 people were diagnosed with the disease in ...
... of online information about the most common sports medicine diagnoses ... 2010 issue of the Journal of Bone and Joint ... help make medical decisions need to know that the web ... that we decided to undertake this study is that patients ...
... , ... Living Website known for their guides to green living have launched their most recent guides ... , ... Growandmake.com the online Guide to Sustainable Living has just released four new lifestyle guides to ...
... ... line of pure, certified organic essential oils. , ... Fargo, ND (Vocus) July 1, 2010-- Aromatherapy isn’t new to the field ... for multiple reasons. From the Greeks to the Romans to modern day, essential oils have ...
... ... to Conventional Medical Treatments. , ... Boca Raton, FL (PRWEB) July 2, 2010 -- Amy, a 55 year-old ... traditional drug treatment, which included five daily pills and injections, Amy,s condition only worsened, ...
... ... clients and brokers on June 23- 24, 2010 near the home office in Irving, Texas. ... National Healthcare Reform and Trends.” The topics covered developments in healthcare reform and factors influencing ... (PRWEB) July ...
Cached Medicine News:Health News:Lymphoma patients with cardiovascular disease have increased risk of cardiac hospitalization 2Health News:Consulting 'Dr. Google' 2Health News:Consulting 'Dr. Google' 3Health News:Growandmake.com Launches New Sustainable Living Guides 2Health News:Certified Organic Aromatherapy Oils Available from Swanson Health Products 2Health News:New Approach to Rheumatoid Arthritis 2Health News:New Approach to Rheumatoid Arthritis 3Health News:HealthSmart Hosts First Forum on National Healthcare Reform and Trends 2
(Date:6/17/2013)... June 17, 2013 Breezy , ... their first product this week using a platform technology enabling ... combats halitosis (bad breath) is being sold in major Israeli ... This commercial launch in Israel follows ... and Spain earlier this year, with ...
(Date:6/17/2013)... N.J. , June 17, 2013 ... announced today a definitive agreement to acquire Aragon ... company focused on drugs to treat hormonally-driven cancers. ... receptor antagonist program.  Aragon,s lead product candidate is ... in Phase 2 development for castration resistant prostate ...
(Date:6/17/2013)... Calif. , June 17, 2013  Imprimis ... announced it has completed the acquisition of intellectual ... from the compounding pharmacy operations of ... allows Imprimis to pursue the commercial development of ... a right of first refusal on additional Buderer ...
Breaking Medicine Technology:A Big "LIKE" for Oral Hygiene 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 2Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 4Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 5
... 26, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, today announced that it will report its ... after the U.S. market closes on May 9, 2011. Mindray,s ... on May 10, 2011 U.S. Eastern Time (8:00 PM on ...
... 2011 Protect Pharmaceutical Corporation (OTCBB: PRTT) today announced ... Officer Ramesha Sesha as its Chief Executive Officer and ... Protect as the Chief Operating Officer and Board Member ... Nectid Inc where he was the Founder and CEO. ...
Cached Medicine Technology:Mindray to Report First Quarter 2011 Financial Results on May 9, 2011 2Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2
... by Dr. Earl Crouch ... for corneal and scleral ... to rest on the ... cornea. Easily removed with ...
Accommodates either eye. Slotted, malleable aluminum surface. Correct size holes produce ideal pin hole effect. Packaged 50 per box....
Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
Child size. Clear plastic. Accommodates either eye. Packaged 12 per box. Available in either adult or pediatric size....
Medicine Products: